In particular, an EBNA2 peptide obtains a sensitivity comparable to current diagnostic assays, and shows strong sequence similarity to the pro-filaggrin peptide originally used for ACPA identification and RA diagnosis [8,12,27]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.